Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)

China flag China · Delayed Price · Currency is CNY
3.840
0.00 (0.00%)
May 12, 2026, 3:00 PM CST
Market Cap2.50B -50.1%
Revenue (ttm)173.47M -33.9%
Net Income-316.00M
EPS-0.47
Shares Out651.90M
PE Ration/a
Forward PEn/a
Dividend0.08 (2.04%)
Ex-Dividend DateJul 15, 2025
Volume28,000,577
Average Volume20,705,281
Open3.930
Previous Close3.840
Day's Range3.790 - 3.960
52-Week Range3.520 - 7.940
Beta0.28
RSI38.76
Earnings DateApr 30, 2026

About SHA:603718

Shanghai Hile Bio-Technology Co., Ltd. develops, manufactures, and sells in vitro diagnostic reagents and oral tissue repair and regeneration materials in China. It operates through two segments: In Vitro Diagnostic Reagents and Oral Tissue Repair and Regeneration Materials. The In Vitro Diagnostic Reagents segment offers biochemical diagnostic reagents, immuno-latex reagents, immune turbidimetry reagents, latex enhanced immune turbidimetry reagents, enzyme-linked immunosorbent products, and related diagnostic kits, including matrix metalloprot... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 366
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603718
Full Company Profile

Financial Performance

Financial Statements